✦ LIBER ✦

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

✍ Scribed by Yoshimasa Aso; Noriyuki Ozeki; Tomoko Terasawa; Rika Naruse; Kenji Hara; Mariko Suetsugu; Kohzo Takebayashi; Mitsuei Shibazaki; Kohsuke Haruki; Kimio Morita; Toshihiko Inukai

Book ID: 118501708
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 210 KB
Volume: 159
Category: Article
ISSN: 1931-5244
DOI: 10.1016/j.trsl.2011.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of the Dipeptidyl Pe

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone

✍ Charbonnel, B.; Karasik, A.; Liu, J.; Wu, M.; Meininger, G. 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 148 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone

✍ Rhee, E. J.; Lee, W. Y.; Min, K. W.; Shivane, V. K.; Sosale, A. R.; Jang, H. C.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Efficacy and safety of adding the dipept

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study

✍ M. A. Nauck; G. C. Ellis; P. R. Fleck; C. A. Wilson; Q. Mekki; for the Aloglipti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Effect of adding sitagliptin, a dipeptid

Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and β-cell function in patients with type 2 diabetes

✍ R. Brazg; L. Xu; C. Dalla Man; C. Cobelli; K. Thomas; P. P. Stein 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB